Skip to main content
. 2013 May 7;10(5):e1001424. doi: 10.1371/journal.pmed.1001424

Table 2. Characteristics of mothers surveyed with a child under 2 y of age in the PEARL Study.

Characteristic Côte D'Ivoire Cameroon Zambia South Africa Total
N Value N Value N Value N Value N Value
Participation in survey 1,869 1,751 (93.7%) 2,451 2,423 (98.9%) 2,347 2,116 (90.2%) 2,939 2,029 (69.0%) 9,606 8,319 (86.6%)
Caregiver interviewed instead of mother 1,731 2 (0.1%) 2,412 25 (1.0%) 2,110 18 (0.9%) 2,013 121 (6.0%) 8,266 166 (2.0%)
Age at time of survey (median [IQR]) 1,730 26 (21, 30) 2,404 25 (22, 30) 2,112 25 (21, 31) 2,026 25 (21, 32) 8,272 25 (21, 30)
12–19 y 227 (13.1%) 276 (11.5%) 285 (13.5%) 312 (15.4%) 1,100 (13.3%)
20–29 y 995 (57.5%) 1,487 (61.9%) 1,211 (57.4%) 1,074 (53.0%) 4,767 (57.6%)
30+ y 508 (29.4%) 639 (26.6%) 615 (29.1%) 640 (31.6%) 2,402 (29.0%)
Parity (median [IQR]) 1,558 2 (1, 3) 2,394 2 (1, 3) 2,084 2 (1, 4) 1,918 2 (1, 3) 7,954 2 (1, 3)
1 638 (40.9%) 812 (33.9%) 681 (32.7%) 861 (44.9%) 2,992 (37.6%)
2 500 (32.1%) 575 (24.0%) 461 (22.1%) 534 (27.8%) 2,070 (26.0%)
3+ 420 (27.0%) 1,007 (42.1%) 942 (45.2%) 523 (27.3%) 2,892 (36.4%)
Marital status 1,726 2,414 2,103 2,019 8,262
Married/cohabitating 1,513 (87.7%) 1,878 (77.8%) 1,655 (78.7%) 870 (43.1%) 5,916 (71.6%)
Other 213 (12.3%) 536 (22.2%) 448 (21.3%) 1,149 (56.9%) 2,346 (28.4%)
Education 1,723 2,401 2,100 2,019 8,243
Secondary or higher 221 (12.8%) 980 (40.8%) 872 (41.5%) 1,682 (83.3%) 3,755 (45.6%)
No schooling or primary 1,502 (87.2%) 1,421 (59.2%) 1,228 (58.5%) 337 (16.7%) 4,488 (54.4%)
Mother currently employed 1,562 2,393 2,071 1,921 7,947
Yes 640 (41.0%) 1,600 (66.9%) 1,136 (54.9%) 372 (19.4%) 3,748 (47.2%)
No 922 (59.0%) 793 (33.1%) 935 (45.1%) 1,549 (80.6%) 4,199 (52.8%)
Maternal HIV status (lab data) 1,325 2,247 1,968 1,917 7,457
Positive 52 (3.9%) 167 (7.4%) 464 (23.6%) 379 (19.8%) 1,062 (14.2%)
Negative 1,265 (95.5%) 2,076 (92.4%) 1,499 (76.2%) 1,515 (79.0%) 6,355 (85.2%)
Mother dead 8 (0.6%) 4 (0.2%) 5 (0.3%) 23 (1.2%) 40 (0.5%)
PMTCT regimen 48 160 450 363 1,021
None 25 (52.1%) 77 (48.1%) 240 (53.3%) 222 (61.2%) 564 (55.2%)
NVP only 1 (2.1%) 37 (23.1%) 48 (10.7%) 62 (17.1%) 148 (14.5%)
NVP+zidovudine 0 (0.0%) 40 (25.0%) 98 (21.8%) 46 (12.7%) 184 (18.0%)
HAART 22 (45.8%) 6 (3.8%) 64 (14.2%) 33 (9.1%) 125 (12.2%)

Data are number (percent) unless otherwise indicated.